8-K//Current report
NASTECH PHARMACEUTICAL CO INC 8-K
Accession 0000950123-05-008871
CIK 0000737207operating
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 3:22 PM ET
Size
100.7 KB
Accession
0000950123-05-008871
Documents
- 8-Ky11062e8vk.htmPrimary
FORM 8-K
- EX-3.1y11062exv3w1.txt
EX-3.1: RESTATED CERTIFICATE OF INCORPORATION
- EX-10.1y11062exv10w1.txt
EX-10.1: RESTRICTED STOCK GRANT AGREEMENT
- EX-10.2y11062exv10w2.txt
EX-10.2: INCENTIVE STOCK OPTION GRANT AGREEMENT
- EX-10.3y11062exv10w3.txt
EX-10.3: NON-QUALIFIED STOCK OPTION GRANT AGREEMENT
- EX-10.4y11062exv10w4.txt
EX-10.4: AMENDMENT NO. 1 TO 2004 STOCK INCENTIVE PLAN
- EX-99.1y11062exv99w1.txt
EX-99.1: PRESS RELEASE
Issuer
Adhera Therapeutics, Inc.
CIK 0000737207
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000737207
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 3:22 PM ET
- Size
- 100.7 KB